business

BofA Trims Becton Dickinson (BDX) Target as Medtech Headwinds Persist

Yahoo Finance · Jun 15, 2026, 7:24 PM · Also reported by 2 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Freedom Broker initiates Sanara MedTech stock with buy rating, $35 target Investing.com BofA raises Jabil stock price target on AI revenue growth outlook

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

BofA Trims Becton Dickinson (BDX) Target as Medtech Headwinds Persist

Also covered by

More in business